How Does Personalized Medicine Relate to Cancer Subtypes?
Personalized medicine involves tailoring medical treatment to the individual characteristics of each patient, often based on the specific subtype of cancer they have. By understanding the genetic and molecular profile of a patient's cancer, healthcare providers can select therapies that are more likely to be effective. For instance:
Patients with HER2-positive breast cancer may benefit from targeted therapies like trastuzumab (Herceptin). Patients with EGFR-mutant lung cancer may respond well to EGFR inhibitors like erlotinib. Patients with MSI-H colorectal cancer may be candidates for immunotherapy.
